Neonatal Alloimmune Neutropenia
- PMID: 31049048
- PMCID: PMC6489100
- DOI: 10.1159/000492949
Neonatal Alloimmune Neutropenia
Abstract
Neonatal alloimmune neutropenia (NAIN, NAIN or NIN) is a neutrophil blood group antagonism, analogous to hemolytic disease of the fetus and newborn (HDFN) and fetal/neonatal alloimmune thrombocytopenia (FNAIT). A limited number of prospective screening studies showed that granulocyte-specific antibodies were detectable in 0.35-1.1% of random postnatal maternal samples and that the incidence of NAIN was below 0.1%. Symptoms vary from none to mild skin infections, omphalitis or more severe infections like pneumonia, sepsis, and meningitis. Treatment of neonatal infection with antibiotics and granulocyte-colony stimulating factor is advised.
Keywords: Fetal alloimmune thrombocytopenia; Hemolytic disease of the newborn; Neonatal alloimmune neutropenia.
References
-
- Slobody LB, Abramson H, LS Jr. Agranulocytosis of the newborn infant. JAMA. 1950;142:25. - PubMed
-
- Lehndorff H. Transitorische Granulocytopenie beim Neugcborenen. Helv. Paediat. Acta. 1951;6:173. - PubMed
-
- Lalezari P, Nussbaum M, Gelman S, Spaet T. Neonatal neutropenia due to maternal immunization. Blood. 1960;15:236–243. - PubMed
-
- Lalezari P, Radel E. Neutrophil-specific antigens: immunology and clinical significance. Semin Hematol. 1974;11:281–290. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
